The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology.
作者信息
Cheng Richard K, Ky Bonnie
出版信息
JACC CardioOncol. 2022 Dec 6;5(1):131-132. doi: 10.1016/j.jaccao.2022.11.013. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology.
JACC CardioOncol. 2022 Dec 6;5(1):131-132. doi: 10.1016/j.jaccao.2022.11.013. eCollection 2023 Feb.
2
Erratum to: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC).勘误：《2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南》：由欧洲心脏病学会（ESC）心脏肿瘤学特别工作组制定。
Eur Heart J. 2023 May 7;44(18):1621. doi: 10.1093/eurheartj/ehad196.
3
[2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].[2022年欧洲心脏病学会心脏肿瘤学指南：理解和治疗癌症治疗的心血管副作用]
Herz. 2023 Feb;48(1):15-22. doi: 10.1007/s00059-022-05149-z. Epub 2022 Nov 28.
4
[2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)].[2022年欧洲心脏病学会与欧洲血液学协会（EHA）、欧洲治疗放射学和肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心血管肿瘤学指南]
G Ital Cardiol (Rome). 2023 Feb;24(2 Suppl 1):e1-e130. doi: 10.1714/3967.39463.
5
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey.意大利心脏肿瘤学概况：全国性意大利医院心脏病专家协会（ANMCO）调查结果
Front Cardiovasc Med. 2021 Jun 16;8:677544. doi: 10.3389/fcvm.2021.677544. eCollection 2021.
6
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).心血管影像学在接受心脏毒性治疗的癌症患者中的作用：代表心力衰竭协会（HFA）、欧洲心血管影像协会（EACVI）和欧洲心脏病学会心脏肿瘤学委员会（ESC）的立场声明。
Eur J Heart Fail. 2020 Sep;22(9):1504-1524. doi: 10.1002/ejhf.1957. Epub 2020 Aug 21.
7
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):e333-e465. doi: 10.1093/ehjci/jeac106.
8
The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China.《2022年欧洲心脏病学会心脏肿瘤学指南对中国临床实践的潜在影响》
JACC CardioOncol. 2023 Feb 21;5(1):153-155. doi: 10.1016/j.jaccao.2023.01.003. eCollection 2023 Feb.
9
ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?
Eur Heart J. 2023 Mar 14;44(11):912-915. doi: 10.1093/eurheartj/ehac701.
10
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用：心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
引用本文的文献
1
Silver Jubilee of HER2 targeting: a clinical success in breast cancer.HER2靶向治疗二十五周年：乳腺癌治疗领域的临床成功典范
J Natl Cancer Cent. 2025 Feb 12;5(4):379-391. doi: 10.1016/j.jncc.2024.12.008. eCollection 2025 Aug.
2
Priorities in Cardio-Oncology: Filling the Gaps in Evidence.心脏肿瘤学的优先事项：填补证据空白
JACC CardioOncol. 2024 Sep 24;6(5):811. doi: 10.1016/j.jaccao.2024.09.002. eCollection 2024 Oct.
3
Association between global longitudinal strain and occurrence of cardiovascular events among pediatric patients following high-dose cyclophosphamide chemotherapy: a prospective cohort study.高剂量环磷酰胺化疗后儿科患者的整体纵向应变与心血管事件发生之间的关联：一项前瞻性队列研究
Transl Pediatr. 2024 Jul 31;13(7):1061-1070. doi: 10.21037/tp-24-119. Epub 2024 Jul 24.
本文引用的文献
1
The Impact of the Cancer Moonshot on Cardio-Oncology Science.癌症“登月计划”对心脏肿瘤学科学的影响。
JACC CardioOncol. 2022 Sep 20;4(3):413-416. doi: 10.1016/j.jaccao.2022.08.004. eCollection 2022 Sep.
2
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
3
My Hope for Cardio-Oncology.我对心脏肿瘤学的期望。
JACC CardioOncol. 2022 Jun 21;4(2):286. doi: 10.1016/j.jaccao.2022.06.001. eCollection 2022 Jun.
4
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.癌症患者及癌症幸存者的心血管健康：迈向新高度的路线图。
J Am Coll Cardiol. 2015 Jun 30;65(25):2739-46. doi: 10.1016/j.jacc.2015.04.059.
5
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.癌症治疗期间及之后成年患者多模态成像评估的专家共识：美国超声心动图学会和欧洲心血管影像学会报告
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39. doi: 10.1016/j.echo.2014.07.012.
Zotero 插件